Etablishment of Follow-up System and End-Stage Heart Registration Platform for Pediatric Heart Failure
A Comprehensive Research of Pediatric Heart Failure-- Etablishment of Follow-up System and End-Stage Heart Registration Platform for Pediatric Heart Failure
1 other identifier
observational
100
1 country
1
Brief Summary
Establish a follow-up management system for pediatric heart failure and a registration platform for end-stage heart failure
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedFirst Submitted
Initial submission to the registry
March 28, 2024
CompletedFirst Posted
Study publicly available on registry
April 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 22, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedMay 28, 2024
March 1, 2024
2.5 years
March 28, 2024
May 23, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the recurrence rate of heart failure
During follow-up visits, echocardiographic examination is conducted to measure the left ventricular function. If LVEF falls under 55%, it is recorded as a recurrence.
6 months
Secondary Outcomes (3)
NT-proBNP level
6 months
Incidence rate of drug adverse reactions
6 months
Readmission rate for heart failure
6 months
Study Arms (1)
End-Stage Heart Failure Group
Children with end-stage heart failure
Interventions
Eligibility Criteria
Children with end-stage heart failure
You may qualify if:
- Patients younger than 14 years of age
- refractory heart failure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- China National Center for Cardiovascular Diseaseslead
- Peking University First Hospitalcollaborator
- Beijing Children's Hospitalcollaborator
Study Sites (1)
Fuwai hospital
Beijing, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Shoujun Li
Chinese Academy of Medical Sciences, Fuwai Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 28, 2024
First Posted
April 3, 2024
Study Start
January 1, 2022
Primary Completion
June 22, 2024
Study Completion
December 31, 2024
Last Updated
May 28, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share